0
0
Generated News

Arthur Hayes Leads $6.9M Raise for BIO Protocol

The Maelstrom Fund founder is betting the next big crypto breakout will be in biotech.
0
0
Sep 17, 20251 min read

Arthur Hayes, current CIO of the Maelstrom Fund, is doubling down on decentralized science, with his firm leading a nearly $7 million seed investment into Bio Protocol.

What’s the Scoop?

  • $6.9M for DeSci’s New Star: Bio Protocol’s seed raise was anchored by Maelstrom, with Mechanism Capital, Animoca Brands, and Atria Ventures joining in.
  • Hayes Sees a New Launchpad: Calling Bio “a category-defining launchpad,” Hayes said it aims to fund research based on community appeal rather than academic gatekeeping. If successful, it could birth a new AI-native research market.
  • AI-Powered Science Agents: Bio Protocol’s platform allows users to deploy BioAgents – autonomous AI “co-scientists” that generate hypotheses, manage wallets, and commercialize discoveries.
Decoding BIO Protocol & DeSci’s Big Dreams on Bankless
How Decentralized Science teams are gearing up to tackle moonshot challenges through onchain coordination.

Not financial or tax advice. This newsletter is strictly educational and is not investment advice or a solicitation to buy or sell any assets or to make any financial decisions. This newsletter is not tax advice. Talk to your accountant. Do your own research.

Disclosure. From time-to-time I may add links in this newsletter to products I use. I may receive commission if you make a purchase through one of these links. Additionally, the Bankless writers hold crypto assets. See our investment disclosures here.